Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

By afschroeder • September 23, 2025

Deo R, Choudhary MC, Glover OT, Ignacio RB, Boucau J, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Aga E, Gibbs M, Cohen T, Streicher K, Soboleva K, Fletcher CV, Daar ES, Greninger AL, Coombs RW, Fischer W, Hughes MD, Smith D, Wohl DA, Barczak AK, Li JZ. Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy. Open Forum Infect Dis. 2025 Sep 8;12(9):ofaf542. doi: 10.1093/ofid/ofaf542. PMID: 40980587; PMCID: PMC12449731.

Tags: Harbor UCLA, Infectious Diseases, intramuscular administration, Monoclonal antibodies, Publications, SARS-CoV-2, tixagevimab/cilgavimab, viral culture conversion

MUCOR-ADVANCE: Uniting multidisciplinary science to defeat a deadly fungus

Wurster S, Stewart AG, Gu Y, Youssef EG, John TM, Uppuluri P, Chamilos G, Filler S, Bruno V, Ibrahim AS, Kontoyiannis DP; MUCOR-ADVANCE consortium. MUCOR-ADVANCE:[...]

Greener Prescribing: A Quasi-Experimental Study of the Environmental Impact of Metronidazole Dosing Interval Optimization

Alsoubani M, Campion M, Swarup S, Lee P, Pearl A, Foong KS. Greener Prescribing: A Quasi-Experimental Study of the Environmental Impact of Metronidazole Dosing Interval[...]

Association of Estimated GFR at the Time of Peritoneal Dialysis Catheter Insertion With Dialysis-Related Complications

Dhoot A, Quinn RR, Clarke A, Armstrong S, Burdick R, Jain AK, Jassal SV, Kennealey PT, Liebman S, McCormick BB, Momciu B, Pauly RP, Perl[...]